nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—Levorphanol—Estrone—prostate cancer	0.212	0.569	CrCrCtD
Dihydrocodeine—CYP3A4—prostate cancer	0.167	1	CbGaD
Dihydrocodeine—Levorphanol—Estradiol—prostate cancer	0.161	0.431	CrCrCtD
Dihydrocodeine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0477	0.154	CbGbCtD
Dihydrocodeine—CYP2D6—Bicalutamide—prostate cancer	0.0394	0.128	CbGbCtD
Dihydrocodeine—CYP2D6—Abiraterone—prostate cancer	0.0327	0.106	CbGbCtD
Dihydrocodeine—CYP3A4—Bicalutamide—prostate cancer	0.0251	0.0811	CbGbCtD
Dihydrocodeine—CYP3A4—Estramustine—prostate cancer	0.0233	0.0754	CbGbCtD
Dihydrocodeine—CYP3A4—Flutamide—prostate cancer	0.0208	0.0672	CbGbCtD
Dihydrocodeine—CYP3A4—Abiraterone—prostate cancer	0.0208	0.0672	CbGbCtD
Dihydrocodeine—CYP3A4—Cabazitaxel—prostate cancer	0.0154	0.0497	CbGbCtD
Dihydrocodeine—CYP3A4—Estrone—prostate cancer	0.015	0.0486	CbGbCtD
Dihydrocodeine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0134	0.0433	CbGbCtD
Dihydrocodeine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00983	0.0318	CbGbCtD
Dihydrocodeine—CYP3A4—Mitoxantrone—prostate cancer	0.00893	0.0289	CbGbCtD
Dihydrocodeine—CYP3A4—Estradiol—prostate cancer	0.00863	0.0279	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisone—prostate cancer	0.00742	0.024	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—prostate cancer	0.00604	0.0196	CbGbCtD
Dihydrocodeine—CYP3A4—Etoposide—prostate cancer	0.00563	0.0182	CbGbCtD
Dihydrocodeine—CYP3A4—Docetaxel—prostate cancer	0.00516	0.0167	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—prostate cancer	0.00384	0.0124	CbGbCtD
Dihydrocodeine—Dextromethorphan—PGRMC1—prostate cancer	0.000987	0.27	CrCbGaD
Dihydrocodeine—Morphine—UGT2B15—prostate cancer	0.000712	0.195	CrCbGaD
Dihydrocodeine—Galantamine—ACHE—prostate cancer	0.000271	0.0742	CrCbGaD
Dihydrocodeine—Codeine—SLC22A1—prostate cancer	0.000237	0.0647	CrCbGaD
Dihydrocodeine—Oxycodone—CYP3A5—prostate cancer	0.0002	0.0547	CrCbGaD
Dihydrocodeine—Codeine—CYP3A5—prostate cancer	0.000191	0.0522	CrCbGaD
Dihydrocodeine—Dry mouth—Estradiol—prostate cancer	0.000164	0.0016	CcSEcCtD
Dihydrocodeine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000163	0.00159	CcSEcCtD
Dihydrocodeine—Confusional state—Estradiol—prostate cancer	0.000163	0.00158	CcSEcCtD
Dihydrocodeine—Urticaria—Goserelin—prostate cancer	0.000162	0.00157	CcSEcCtD
Dihydrocodeine—Abdominal pain—Goserelin—prostate cancer	0.000161	0.00156	CcSEcCtD
Dihydrocodeine—Urticaria—Conjugated Estrogens—prostate cancer	0.00016	0.00156	CcSEcCtD
Dihydrocodeine—Angiopathy—Etoposide—prostate cancer	0.00016	0.00155	CcSEcCtD
Dihydrocodeine—Convulsion—Mitoxantrone—prostate cancer	0.000159	0.00155	CcSEcCtD
Dihydrocodeine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000159	0.00155	CcSEcCtD
Dihydrocodeine—Immune system disorder—Etoposide—prostate cancer	0.000159	0.00155	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Etoposide—prostate cancer	0.000158	0.00154	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Estradiol—prostate cancer	0.000158	0.00154	CcSEcCtD
Dihydrocodeine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000157	0.00153	CcSEcCtD
Dihydrocodeine—Skin disorder—Estradiol—prostate cancer	0.000157	0.00152	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Estradiol—prostate cancer	0.000156	0.00152	CcSEcCtD
Dihydrocodeine—Rash—Ethinyl Estradiol—prostate cancer	0.000156	0.00152	CcSEcCtD
Dihydrocodeine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000156	0.00151	CcSEcCtD
Dihydrocodeine—Headache—Ethinyl Estradiol—prostate cancer	0.000155	0.00151	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Docetaxel—prostate cancer	0.000154	0.0015	CcSEcCtD
Dihydrocodeine—Confusional state—Mitoxantrone—prostate cancer	0.000151	0.00147	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Capecitabine—prostate cancer	0.000149	0.00145	CcSEcCtD
Dihydrocodeine—Nausea—Ethinyl Estradiol—prostate cancer	0.000147	0.00143	CcSEcCtD
Dihydrocodeine—Skin disorder—Mitoxantrone—prostate cancer	0.000146	0.00142	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000145	0.00141	CcSEcCtD
Dihydrocodeine—Paraesthesia—Estradiol—prostate cancer	0.000145	0.00141	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Docetaxel—prostate cancer	0.000144	0.0014	CcSEcCtD
Dihydrocodeine—Pruritus—Goserelin—prostate cancer	0.000144	0.0014	CcSEcCtD
Dihydrocodeine—Dyspnoea—Estradiol—prostate cancer	0.000144	0.0014	CcSEcCtD
Dihydrocodeine—Somnolence—Estradiol—prostate cancer	0.000143	0.00139	CcSEcCtD
Dihydrocodeine—Urethral disorder—Docetaxel—prostate cancer	0.000143	0.00139	CcSEcCtD
Dihydrocodeine—Pruritus—Conjugated Estrogens—prostate cancer	0.000143	0.00139	CcSEcCtD
Dihydrocodeine—Hypotension—Mitoxantrone—prostate cancer	0.00014	0.00137	CcSEcCtD
Dihydrocodeine—Affect lability—Epirubicin—prostate cancer	0.00014	0.00136	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Capecitabine—prostate cancer	0.00014	0.00136	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Estradiol—prostate cancer	0.000139	0.00135	CcSEcCtD
Dihydrocodeine—Diarrhoea—Goserelin—prostate cancer	0.000139	0.00135	CcSEcCtD
Dihydrocodeine—Urethral disorder—Capecitabine—prostate cancer	0.000139	0.00135	CcSEcCtD
Dihydrocodeine—Constipation—Estradiol—prostate cancer	0.000138	0.00134	CcSEcCtD
Dihydrocodeine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000138	0.00134	CcSEcCtD
Dihydrocodeine—Vertigo—Etoposide—prostate cancer	0.000138	0.00134	CcSEcCtD
Dihydrocodeine—Mood swings—Epirubicin—prostate cancer	0.000135	0.00131	CcSEcCtD
Dihydrocodeine—Paraesthesia—Mitoxantrone—prostate cancer	0.000135	0.00131	CcSEcCtD
Dihydrocodeine—Dizziness—Goserelin—prostate cancer	0.000134	0.00131	CcSEcCtD
Dihydrocodeine—Dyspnoea—Mitoxantrone—prostate cancer	0.000134	0.0013	CcSEcCtD
Dihydrocodeine—Somnolence—Mitoxantrone—prostate cancer	0.000134	0.0013	CcSEcCtD
Dihydrocodeine—Dizziness—Conjugated Estrogens—prostate cancer	0.000133	0.0013	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Estradiol—prostate cancer	0.000133	0.00129	CcSEcCtD
Dihydrocodeine—Convulsion—Etoposide—prostate cancer	0.000133	0.00129	CcSEcCtD
Dihydrocodeine—Angiopathy—Docetaxel—prostate cancer	0.000133	0.00129	CcSEcCtD
Dihydrocodeine—Immune system disorder—Docetaxel—prostate cancer	0.000132	0.00128	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Estradiol—prostate cancer	0.000132	0.00128	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Docetaxel—prostate cancer	0.000132	0.00128	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP3A5—prostate cancer	0.00013	0.0355	CrCbGaD
Dihydrocodeine—Affect lability—Doxorubicin—prostate cancer	0.00013	0.00126	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000129	0.00126	CcSEcCtD
Dihydrocodeine—Vomiting—Goserelin—prostate cancer	0.000129	0.00126	CcSEcCtD
Dihydrocodeine—Constipation—Mitoxantrone—prostate cancer	0.000128	0.00125	CcSEcCtD
Dihydrocodeine—Angiopathy—Capecitabine—prostate cancer	0.000128	0.00125	CcSEcCtD
Dihydrocodeine—Rash—Goserelin—prostate cancer	0.000128	0.00125	CcSEcCtD
Dihydrocodeine—Dermatitis—Goserelin—prostate cancer	0.000128	0.00125	CcSEcCtD
Dihydrocodeine—Vomiting—Conjugated Estrogens—prostate cancer	0.000128	0.00125	CcSEcCtD
Dihydrocodeine—Urticaria—Estradiol—prostate cancer	0.000128	0.00125	CcSEcCtD
Dihydrocodeine—Mental disorder—Docetaxel—prostate cancer	0.000128	0.00125	CcSEcCtD
Dihydrocodeine—Immune system disorder—Capecitabine—prostate cancer	0.000128	0.00124	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Capecitabine—prostate cancer	0.000128	0.00124	CcSEcCtD
Dihydrocodeine—Abdominal pain—Estradiol—prostate cancer	0.000127	0.00124	CcSEcCtD
Dihydrocodeine—Headache—Goserelin—prostate cancer	0.000127	0.00124	CcSEcCtD
Dihydrocodeine—Rash—Conjugated Estrogens—prostate cancer	0.000127	0.00124	CcSEcCtD
Dihydrocodeine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000127	0.00123	CcSEcCtD
Dihydrocodeine—Headache—Conjugated Estrogens—prostate cancer	0.000126	0.00123	CcSEcCtD
Dihydrocodeine—Confusional state—Etoposide—prostate cancer	0.000126	0.00123	CcSEcCtD
Dihydrocodeine—Hallucination—Prednisone—prostate cancer	0.000125	0.00122	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—prostate cancer	0.000125	0.00122	CcSEcCtD
Dihydrocodeine—Mental disorder—Capecitabine—prostate cancer	0.000124	0.00121	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000124	0.0012	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000123	0.00119	CcSEcCtD
Dihydrocodeine—Skin disorder—Etoposide—prostate cancer	0.000121	0.00118	CcSEcCtD
Dihydrocodeine—Nausea—Goserelin—prostate cancer	0.000121	0.00118	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Etoposide—prostate cancer	0.000121	0.00118	CcSEcCtD
Dihydrocodeine—Nausea—Conjugated Estrogens—prostate cancer	0.00012	0.00116	CcSEcCtD
Dihydrocodeine—Urticaria—Mitoxantrone—prostate cancer	0.000119	0.00116	CcSEcCtD
Dihydrocodeine—Abdominal pain—Mitoxantrone—prostate cancer	0.000119	0.00116	CcSEcCtD
Dihydrocodeine—Hypotension—Etoposide—prostate cancer	0.000117	0.00114	CcSEcCtD
Dihydrocodeine—Angiopathy—Prednisone—prostate cancer	0.000114	0.00111	CcSEcCtD
Dihydrocodeine—Pruritus—Estradiol—prostate cancer	0.000114	0.00111	CcSEcCtD
Dihydrocodeine—Immune system disorder—Prednisone—prostate cancer	0.000114	0.00111	CcSEcCtD
Dihydrocodeine—Paraesthesia—Etoposide—prostate cancer	0.000112	0.00109	CcSEcCtD
Dihydrocodeine—Dyspnoea—Etoposide—prostate cancer	0.000111	0.00108	CcSEcCtD
Dihydrocodeine—Somnolence—Etoposide—prostate cancer	0.000111	0.00108	CcSEcCtD
Dihydrocodeine—Vertigo—Capecitabine—prostate cancer	0.000111	0.00108	CcSEcCtD
Dihydrocodeine—Mental disorder—Prednisone—prostate cancer	0.00011	0.00107	CcSEcCtD
Dihydrocodeine—Diarrhoea—Estradiol—prostate cancer	0.00011	0.00107	CcSEcCtD
Dihydrocodeine—Convulsion—Docetaxel—prostate cancer	0.00011	0.00107	CcSEcCtD
Dihydrocodeine—Oxymorphone—CYP3A4—prostate cancer	0.000109	0.0297	CrCbGaD
Dihydrocodeine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000108	0.00105	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000108	0.00105	CcSEcCtD
Dihydrocodeine—Constipation—Etoposide—prostate cancer	0.000107	0.00104	CcSEcCtD
Dihydrocodeine—Dizziness—Estradiol—prostate cancer	0.000107	0.00104	CcSEcCtD
Dihydrocodeine—Dry mouth—Docetaxel—prostate cancer	0.000106	0.00103	CcSEcCtD
Dihydrocodeine—Confusional state—Docetaxel—prostate cancer	0.000105	0.00102	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000104	0.00101	CcSEcCtD
Dihydrocodeine—Ethylmorphine—CYP3A4—prostate cancer	0.000104	0.0284	CrCbGaD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—prostate cancer	0.000104	0.00101	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etoposide—prostate cancer	0.000103	0.001	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mitoxantrone—prostate cancer	0.000103	0.001	CcSEcCtD
Dihydrocodeine—Dry mouth—Capecitabine—prostate cancer	0.000103	0.000998	CcSEcCtD
Dihydrocodeine—Vomiting—Estradiol—prostate cancer	0.000102	0.000997	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etoposide—prostate cancer	0.000102	0.000994	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Docetaxel—prostate cancer	0.000102	0.000991	CcSEcCtD
Dihydrocodeine—Rash—Estradiol—prostate cancer	0.000102	0.000989	CcSEcCtD
Dihydrocodeine—Dermatitis—Estradiol—prostate cancer	0.000102	0.000988	CcSEcCtD
Dihydrocodeine—Confusional state—Capecitabine—prostate cancer	0.000101	0.000986	CcSEcCtD
Dihydrocodeine—Headache—Estradiol—prostate cancer	0.000101	0.000982	CcSEcCtD
Dihydrocodeine—Skin disorder—Docetaxel—prostate cancer	0.000101	0.000981	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisone—prostate cancer	0.0001	0.000975	CcSEcCtD
Dihydrocodeine—Urticaria—Etoposide—prostate cancer	9.93e-05	0.000966	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etoposide—prostate cancer	9.88e-05	0.000961	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Capecitabine—prostate cancer	9.86e-05	0.000959	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisone—prostate cancer	9.86e-05	0.000959	CcSEcCtD
Dihydrocodeine—Skin disorder—Capecitabine—prostate cancer	9.76e-05	0.00095	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—prostate cancer	9.74e-05	0.000947	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Capecitabine—prostate cancer	9.72e-05	0.000945	CcSEcCtD
Dihydrocodeine—Hypotension—Docetaxel—prostate cancer	9.7e-05	0.000944	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—prostate cancer	9.66e-05	0.00094	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—prostate cancer	9.61e-05	0.000935	CcSEcCtD
Dihydrocodeine—Nausea—Estradiol—prostate cancer	9.58e-05	0.000932	CcSEcCtD
Dihydrocodeine—Vomiting—Mitoxantrone—prostate cancer	9.55e-05	0.000929	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisone—prostate cancer	9.51e-05	0.000925	CcSEcCtD
Dihydrocodeine—Hydrocodone—CYP3A4—prostate cancer	9.51e-05	0.026	CrCbGaD
Dihydrocodeine—Rash—Mitoxantrone—prostate cancer	9.47e-05	0.000921	CcSEcCtD
Dihydrocodeine—Dermatitis—Mitoxantrone—prostate cancer	9.46e-05	0.000921	CcSEcCtD
Dihydrocodeine—Headache—Mitoxantrone—prostate cancer	9.41e-05	0.000915	CcSEcCtD
Dihydrocodeine—Hypotension—Capecitabine—prostate cancer	9.39e-05	0.000914	CcSEcCtD
Dihydrocodeine—Paraesthesia—Docetaxel—prostate cancer	9.32e-05	0.000907	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	9.28e-05	0.000903	CcSEcCtD
Dihydrocodeine—Dyspnoea—Docetaxel—prostate cancer	9.26e-05	0.000901	CcSEcCtD
Dihydrocodeine—Somnolence—Docetaxel—prostate cancer	9.23e-05	0.000898	CcSEcCtD
Dihydrocodeine—Paraesthesia—Capecitabine—prostate cancer	9.03e-05	0.000878	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—prostate cancer	9.01e-05	0.000876	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Docetaxel—prostate cancer	8.96e-05	0.000872	CcSEcCtD
Dihydrocodeine—Dyspnoea—Capecitabine—prostate cancer	8.96e-05	0.000872	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—prostate cancer	8.94e-05	0.00087	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—prostate cancer	8.94e-05	0.00087	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP2E1—prostate cancer	8.93e-05	0.0244	CrCbGaD
Dihydrocodeine—Nausea—Mitoxantrone—prostate cancer	8.92e-05	0.000868	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—prostate cancer	8.9e-05	0.000866	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—prostate cancer	8.88e-05	0.000864	CcSEcCtD
Dihydrocodeine—Constipation—Docetaxel—prostate cancer	8.88e-05	0.000864	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP2C19—prostate cancer	8.84e-05	0.0242	CrCbGaD
Dihydrocodeine—Pruritus—Etoposide—prostate cancer	8.84e-05	0.00086	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Prednisone—prostate cancer	8.78e-05	0.000854	CcSEcCtD
Dihydrocodeine—Skin disorder—Prednisone—prostate cancer	8.7e-05	0.000846	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Capecitabine—prostate cancer	8.68e-05	0.000844	CcSEcCtD
Dihydrocodeine—Oxycodone—CYP3A4—prostate cancer	8.67e-05	0.0237	CrCbGaD
Dihydrocodeine—Hyperhidrosis—Prednisone—prostate cancer	8.66e-05	0.000842	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—prostate cancer	8.64e-05	0.00084	CcSEcCtD
Dihydrocodeine—Constipation—Capecitabine—prostate cancer	8.6e-05	0.000836	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Docetaxel—prostate cancer	8.56e-05	0.000832	CcSEcCtD
Dihydrocodeine—Diarrhoea—Etoposide—prostate cancer	8.55e-05	0.000832	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Docetaxel—prostate cancer	8.49e-05	0.000826	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Capecitabine—prostate cancer	8.28e-05	0.000806	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—prostate cancer	8.28e-05	0.000805	CcSEcCtD
Dihydrocodeine—Codeine—CYP3A4—prostate cancer	8.28e-05	0.0226	CrCbGaD
Dihydrocodeine—Dizziness—Etoposide—prostate cancer	8.26e-05	0.000804	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—prostate cancer	8.24e-05	0.000802	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Capecitabine—prostate cancer	8.22e-05	0.0008	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—prostate cancer	8.22e-05	0.0008	CcSEcCtD
Dihydrocodeine—Abdominal pain—Docetaxel—prostate cancer	8.21e-05	0.000799	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisone—prostate cancer	8.04e-05	0.000782	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—prostate cancer	7.99e-05	0.000777	CcSEcCtD
Dihydrocodeine—Urticaria—Capecitabine—prostate cancer	7.99e-05	0.000777	CcSEcCtD
Dihydrocodeine—Abdominal pain—Capecitabine—prostate cancer	7.95e-05	0.000773	CcSEcCtD
Dihydrocodeine—Vomiting—Etoposide—prostate cancer	7.94e-05	0.000773	CcSEcCtD
Dihydrocodeine—Rash—Etoposide—prostate cancer	7.88e-05	0.000766	CcSEcCtD
Dihydrocodeine—Hydromorphone—CYP3A4—prostate cancer	7.88e-05	0.0215	CrCbGaD
Dihydrocodeine—Dermatitis—Etoposide—prostate cancer	7.87e-05	0.000766	CcSEcCtD
Dihydrocodeine—Headache—Etoposide—prostate cancer	7.83e-05	0.000761	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—prostate cancer	7.71e-05	0.00075	CcSEcCtD
Dihydrocodeine—Constipation—Prednisone—prostate cancer	7.66e-05	0.000745	CcSEcCtD
Dihydrocodeine—Galantamine—CYP3A4—prostate cancer	7.51e-05	0.0205	CrCbGaD
Dihydrocodeine—Convulsion—Epirubicin—prostate cancer	7.44e-05	0.000723	CcSEcCtD
Dihydrocodeine—Nausea—Etoposide—prostate cancer	7.42e-05	0.000722	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisone—prostate cancer	7.38e-05	0.000718	CcSEcCtD
Dihydrocodeine—Pruritus—Docetaxel—prostate cancer	7.35e-05	0.000715	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Prednisone—prostate cancer	7.32e-05	0.000712	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.26e-05	0.000706	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—prostate cancer	7.15e-05	0.000695	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—prostate cancer	7.13e-05	0.000694	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisone—prostate cancer	7.11e-05	0.000692	CcSEcCtD
Dihydrocodeine—Pruritus—Capecitabine—prostate cancer	7.11e-05	0.000692	CcSEcCtD
Dihydrocodeine—Diarrhoea—Docetaxel—prostate cancer	7.1e-05	0.000691	CcSEcCtD
Dihydrocodeine—Abdominal pain—Prednisone—prostate cancer	7.08e-05	0.000689	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—prostate cancer	7.06e-05	0.000687	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—prostate cancer	6.88e-05	0.000669	CcSEcCtD
Dihydrocodeine—Diarrhoea—Capecitabine—prostate cancer	6.88e-05	0.000669	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—prostate cancer	6.87e-05	0.000668	CcSEcCtD
Dihydrocodeine—Dizziness—Docetaxel—prostate cancer	6.87e-05	0.000668	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—prostate cancer	6.8e-05	0.000662	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—prostate cancer	6.77e-05	0.000659	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.71e-05	0.000653	CcSEcCtD
Dihydrocodeine—Morphine—CYP3A4—prostate cancer	6.7e-05	0.0183	CrCbGaD
Dihydrocodeine—Dizziness—Capecitabine—prostate cancer	6.65e-05	0.000647	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—prostate cancer	6.61e-05	0.000643	CcSEcCtD
Dihydrocodeine—Vomiting—Docetaxel—prostate cancer	6.6e-05	0.000642	CcSEcCtD
Dihydrocodeine—Rash—Docetaxel—prostate cancer	6.55e-05	0.000637	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—prostate cancer	6.54e-05	0.000637	CcSEcCtD
Dihydrocodeine—Dermatitis—Docetaxel—prostate cancer	6.54e-05	0.000636	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—prostate cancer	6.53e-05	0.000636	CcSEcCtD
Dihydrocodeine—Headache—Docetaxel—prostate cancer	6.5e-05	0.000633	CcSEcCtD
Dihydrocodeine—Vomiting—Capecitabine—prostate cancer	6.39e-05	0.000622	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—prostate cancer	6.36e-05	0.000618	CcSEcCtD
Dihydrocodeine—Rash—Capecitabine—prostate cancer	6.34e-05	0.000617	CcSEcCtD
Dihydrocodeine—Pruritus—Prednisone—prostate cancer	6.34e-05	0.000616	CcSEcCtD
Dihydrocodeine—Dermatitis—Capecitabine—prostate cancer	6.33e-05	0.000616	CcSEcCtD
Dihydrocodeine—Headache—Capecitabine—prostate cancer	6.3e-05	0.000613	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—prostate cancer	6.29e-05	0.000612	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—prostate cancer	6.29e-05	0.000612	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—prostate cancer	6.26e-05	0.000609	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—prostate cancer	6.24e-05	0.000607	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—prostate cancer	6.23e-05	0.000606	CcSEcCtD
Dihydrocodeine—Nausea—Docetaxel—prostate cancer	6.17e-05	0.0006	CcSEcCtD
Dihydrocodeine—Diarrhoea—Prednisone—prostate cancer	6.13e-05	0.000596	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—prostate cancer	6.06e-05	0.000589	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—prostate cancer	6.05e-05	0.000588	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—prostate cancer	5.99e-05	0.000583	CcSEcCtD
Dihydrocodeine—Nausea—Capecitabine—prostate cancer	5.97e-05	0.000581	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisone—prostate cancer	5.92e-05	0.000576	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—prostate cancer	5.82e-05	0.000566	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—prostate cancer	5.78e-05	0.000562	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—prostate cancer	5.77e-05	0.000561	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—prostate cancer	5.76e-05	0.00056	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—prostate cancer	5.73e-05	0.000557	CcSEcCtD
Dihydrocodeine—Vomiting—Prednisone—prostate cancer	5.69e-05	0.000554	CcSEcCtD
Dihydrocodeine—Rash—Prednisone—prostate cancer	5.65e-05	0.000549	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisone—prostate cancer	5.64e-05	0.000549	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP3A4—prostate cancer	5.62e-05	0.0154	CrCbGaD
Dihydrocodeine—Headache—Prednisone—prostate cancer	5.61e-05	0.000546	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.59e-05	0.000544	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—prostate cancer	5.56e-05	0.000541	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—prostate cancer	5.54e-05	0.000539	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—prostate cancer	5.54e-05	0.000539	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—prostate cancer	5.34e-05	0.00052	CcSEcCtD
Dihydrocodeine—Nausea—Prednisone—prostate cancer	5.32e-05	0.000517	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—prostate cancer	5.3e-05	0.000516	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—prostate cancer	5.15e-05	0.000501	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—prostate cancer	5.12e-05	0.000498	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—prostate cancer	4.96e-05	0.000482	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—prostate cancer	4.79e-05	0.000466	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—prostate cancer	4.63e-05	0.000451	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—prostate cancer	4.58e-05	0.000446	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—prostate cancer	4.45e-05	0.000433	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—prostate cancer	4.43e-05	0.000431	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—prostate cancer	4.42e-05	0.00043	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—prostate cancer	4.41e-05	0.000429	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—prostate cancer	4.39e-05	0.000427	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—prostate cancer	4.29e-05	0.000417	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—prostate cancer	4.16e-05	0.000405	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—prostate cancer	4.12e-05	0.000401	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—prostate cancer	4.09e-05	0.000397	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—prostate cancer	4.08e-05	0.000397	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—prostate cancer	4.06e-05	0.000395	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—prostate cancer	3.85e-05	0.000374	CcSEcCtD
Dihydrocodeine—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.16e-05	0.000263	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GRHPR—prostate cancer	1.16e-05	0.000263	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCZ—prostate cancer	1.15e-05	0.00026	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ACSL4—prostate cancer	1.15e-05	0.000259	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSD17B3—prostate cancer	1.15e-05	0.000259	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CG—prostate cancer	1.12e-05	0.000254	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGFR4—prostate cancer	1.11e-05	0.000251	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PARP1—prostate cancer	1.11e-05	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PHGDH—prostate cancer	1.1e-05	0.000249	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ARG2—prostate cancer	1.1e-05	0.000249	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UMPS—prostate cancer	1.1e-05	0.000249	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CALCA—prostate cancer	1.1e-05	0.000248	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PGAM2—prostate cancer	1.09e-05	0.000247	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.09e-05	0.000247	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AOX1—prostate cancer	1.09e-05	0.000247	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.09e-05	0.000247	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.09e-05	0.000247	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—RFK—prostate cancer	1.09e-05	0.000247	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM3—prostate cancer	1.09e-05	0.000247	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LDHB—prostate cancer	1.08e-05	0.000244	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL12—prostate cancer	1.07e-05	0.000242	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP3A5—prostate cancer	1.06e-05	0.000239	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AMACR—prostate cancer	1.04e-05	0.000235	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.04e-05	0.000235	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.04e-05	0.000235	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.04e-05	0.000235	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NAT1—prostate cancer	1.04e-05	0.000235	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PDHA1—prostate cancer	1.02e-05	0.000231	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TCN2—prostate cancer	1.02e-05	0.000231	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UCP3—prostate cancer	1.02e-05	0.000231	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA3—prostate cancer	1.02e-05	0.000231	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CG—prostate cancer	1.02e-05	0.000231	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP9—prostate cancer	1.01e-05	0.000228	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.9e-06	0.000224	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CD—prostate cancer	9.89e-06	0.000223	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCQ—prostate cancer	9.78e-06	0.000221	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NGFR—prostate cancer	9.78e-06	0.000221	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC22A3—prostate cancer	9.76e-06	0.000221	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSD3B1—prostate cancer	9.76e-06	0.000221	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAP3K7—prostate cancer	9.67e-06	0.000218	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TBXAS1—prostate cancer	9.36e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA4—prostate cancer	9.36e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF10—prostate cancer	9.3e-06	0.00021	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADRB2—prostate cancer	9.2e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA2—prostate cancer	9.12e-06	0.000206	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—JAK2—prostate cancer	9.08e-06	0.000205	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAP2K1—prostate cancer	9.04e-06	0.000204	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SULT1A1—prostate cancer	9.01e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCG5—prostate cancer	9.01e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CD—prostate cancer	8.98e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VAV3—prostate cancer	8.97e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFBR2—prostate cancer	8.84e-06	0.0002	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.83e-06	0.000199	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HPGD—prostate cancer	8.83e-06	0.000199	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA1—prostate cancer	8.8e-06	0.000199	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ITPR1—prostate cancer	8.7e-06	0.000197	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTO1—prostate cancer	8.7e-06	0.000197	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSD3B2—prostate cancer	8.7e-06	0.000197	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NAT2—prostate cancer	8.7e-06	0.000197	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CB—prostate cancer	8.62e-06	0.000195	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2C18—prostate cancer	8.34e-06	0.000188	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LRP2—prostate cancer	8.34e-06	0.000188	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLCB2—prostate cancer	8.34e-06	0.000188	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1R—prostate cancer	8.32e-06	0.000188	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.3e-06	0.000187	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCL8—prostate cancer	8.28e-06	0.000187	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—JAK2—prostate cancer	8.24e-06	0.000186	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—P4HB—prostate cancer	8.18e-06	0.000185	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP7B1—prostate cancer	8.07e-06	0.000182	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTAP—prostate cancer	8.07e-06	0.000182	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LPL—prostate cancer	7.98e-06	0.00018	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC22A1—prostate cancer	7.96e-06	0.00018	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—IL2—prostate cancer	7.92e-06	0.000179	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFRB—prostate cancer	7.91e-06	0.000179	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.87e-06	0.000178	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.87e-06	0.000178	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CB—prostate cancer	7.83e-06	0.000177	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SULT2A1—prostate cancer	7.75e-06	0.000175	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ITGB3—prostate cancer	7.7e-06	0.000174	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MED12—prostate cancer	7.63e-06	0.000172	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GNG5—prostate cancer	7.57e-06	0.000171	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCL8—prostate cancer	7.52e-06	0.00017	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ACSL4—prostate cancer	7.5e-06	0.00017	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.5e-06	0.00017	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB3—prostate cancer	7.47e-06	0.000169	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGFR2—prostate cancer	7.46e-06	0.000169	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA3—prostate cancer	7.29e-06	0.000165	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UMPS—prostate cancer	7.19e-06	0.000163	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PHGDH—prostate cancer	7.19e-06	0.000163	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ARG2—prostate cancer	7.19e-06	0.000163	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL2—prostate cancer	7.19e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TERT—prostate cancer	7.16e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LDHB—prostate cancer	7.06e-06	0.000159	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HPGDS—prostate cancer	6.95e-06	0.000157	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.93e-06	0.000156	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.91e-06	0.000156	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HIF1A—prostate cancer	6.85e-06	0.000155	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ACHE—prostate cancer	6.74e-06	0.000152	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTT1—prostate cancer	6.74e-06	0.000152	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PDHA1—prostate cancer	6.69e-06	0.000151	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA3—prostate cancer	6.69e-06	0.000151	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TCN2—prostate cancer	6.69e-06	0.000151	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UCP3—prostate cancer	6.69e-06	0.000151	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LEP—prostate cancer	6.69e-06	0.000151	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2A6—prostate cancer	6.67e-06	0.000151	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CAV1—prostate cancer	6.62e-06	0.00015	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KDR—prostate cancer	6.55e-06	0.000148	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKR1C3—prostate cancer	6.49e-06	0.000147	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PRKACB—prostate cancer	6.45e-06	0.000146	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP17A1—prostate cancer	6.38e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ESR1—prostate cancer	6.38e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.38e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.38e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BAD—prostate cancer	6.23e-06	0.000141	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA4—prostate cancer	6.12e-06	0.000138	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TBXAS1—prostate cancer	6.12e-06	0.000138	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA2—prostate cancer	6.08e-06	0.000137	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	6.03e-06	0.000136	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APC—prostate cancer	6.03e-06	0.000136	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGF—prostate cancer	5.96e-06	0.000135	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IRS1—prostate cancer	5.96e-06	0.000135	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA2—prostate cancer	5.96e-06	0.000135	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCG5—prostate cancer	5.89e-06	0.000133	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.89e-06	0.000133	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.8e-06	0.000131	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GSK3B—prostate cancer	5.79e-06	0.000131	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA1—prostate cancer	5.75e-06	0.00013	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—INS—prostate cancer	5.71e-06	0.000129	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NAT2—prostate cancer	5.69e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTO1—prostate cancer	5.69e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.69e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2E1—prostate cancer	5.67e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NQO1—prostate cancer	5.61e-06	0.000127	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CREBBP—prostate cancer	5.59e-06	0.000126	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1—prostate cancer	5.52e-06	0.000125	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TH—prostate cancer	5.52e-06	0.000125	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EGFR—prostate cancer	5.5e-06	0.000124	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP3A4—prostate cancer	5.47e-06	0.000124	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLCB2—prostate cancer	5.45e-06	0.000123	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.45e-06	0.000123	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LRP2—prostate cancer	5.45e-06	0.000123	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1B1—prostate cancer	5.37e-06	0.000121	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—P4HB—prostate cancer	5.35e-06	0.000121	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	5.34e-06	0.000121	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	5.3e-06	0.00012	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	5.25e-06	0.000119	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	5.25e-06	0.000119	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GGT1—prostate cancer	5.2e-06	0.000118	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.2e-06	0.000118	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KRAS—prostate cancer	5.19e-06	0.000117	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA1—prostate cancer	5.13e-06	0.000116	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF2—prostate cancer	5.08e-06	0.000115	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.07e-06	0.000115	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP19A1—prostate cancer	5.05e-06	0.000114	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOS3—prostate cancer	5.01e-06	0.000113	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MED12—prostate cancer	4.99e-06	0.000113	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GNG5—prostate cancer	4.95e-06	0.000112	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—RXRA—prostate cancer	4.88e-06	0.00011	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JAK2—prostate cancer	4.87e-06	0.00011	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	4.77e-06	0.000108	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA3—prostate cancer	4.77e-06	0.000108	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MDM2—prostate cancer	4.75e-06	0.000107	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—COMT—prostate cancer	4.7e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB2—prostate cancer	4.69e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTP1—prostate cancer	4.68e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	4.62e-06	0.000104	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ITPR1—prostate cancer	4.6e-06	0.000104	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HPGDS—prostate cancer	4.55e-06	0.000103	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.52e-06	0.000102	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL8—prostate cancer	4.44e-06	0.0001	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ACHE—prostate cancer	4.41e-06	9.96e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTT1—prostate cancer	4.41e-06	9.96e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.36e-06	9.85e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TYMS—prostate cancer	4.35e-06	9.82e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	4.34e-06	9.8e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—prostate cancer	4.3e-06	9.71e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	4.29e-06	9.7e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—prostate cancer	4.25e-06	9.61e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL2—prostate cancer	4.25e-06	9.59e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.24e-06	9.58e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—prostate cancer	4.23e-06	9.55e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PRKACB—prostate cancer	4.22e-06	9.53e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LPL—prostate cancer	4.22e-06	9.53e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.17e-06	9.43e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCND1—prostate cancer	4.14e-06	9.35e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	4.1e-06	9.26e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1A1—prostate cancer	4.07e-06	9.2e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ERCC2—prostate cancer	4.04e-06	9.13e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—prostate cancer	4.02e-06	9.08e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	4e-06	9.05e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTEN—prostate cancer	4e-06	9.03e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA2—prostate cancer	3.98e-06	8.99e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—prostate cancer	3.9e-06	8.81e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EP300—prostate cancer	3.81e-06	8.61e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTHFR—prostate cancer	3.8e-06	8.58e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.79e-06	8.57e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARA—prostate cancer	3.73e-06	8.42e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.71e-06	8.37e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SRC—prostate cancer	3.71e-06	8.37e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NQO1—prostate cancer	3.66e-06	8.28e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TH—prostate cancer	3.61e-06	8.16e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—prostate cancer	3.61e-06	8.15e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT3—prostate cancer	3.57e-06	8.07e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.51e-06	7.94e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CAV1—prostate cancer	3.5e-06	7.91e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GGT1—prostate cancer	3.4e-06	7.69e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA1—prostate cancer	3.35e-06	7.57e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MYC—prostate cancer	3.32e-06	7.5e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFB1—prostate cancer	3.31e-06	7.48e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.3e-06	7.46e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGFR—prostate cancer	3.25e-06	7.34e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.19e-06	7.21e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—RXRA—prostate cancer	3.19e-06	7.2e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—COMT—prostate cancer	3.07e-06	6.94e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KRAS—prostate cancer	3.07e-06	6.93e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTP1—prostate cancer	3.06e-06	6.91e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—INS—prostate cancer	3.02e-06	6.82e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ITPR1—prostate cancer	3.01e-06	6.8e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.96e-06	6.68e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TYMS—prostate cancer	2.84e-06	6.42e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	2.82e-06	6.37e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.81e-06	6.35e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.8e-06	6.34e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LPL—prostate cancer	2.76e-06	6.23e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TP53—prostate cancer	2.73e-06	6.16e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.66e-06	6.02e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NOS3—prostate cancer	2.65e-06	5.98e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ERCC2—prostate cancer	2.64e-06	5.97e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—prostate cancer	2.5e-06	5.64e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTHFR—prostate cancer	2.48e-06	5.61e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.44e-06	5.52e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARA—prostate cancer	2.44e-06	5.5e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.42e-06	5.47e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—prostate cancer	2.3e-06	5.2e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CAV1—prostate cancer	2.29e-06	5.17e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTEN—prostate cancer	2.11e-06	4.77e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.09e-06	4.71e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—EP300—prostate cancer	2.01e-06	4.55e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—INS—prostate cancer	1.97e-06	4.46e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.93e-06	4.37e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.83e-06	4.14e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NOS3—prostate cancer	1.73e-06	3.91e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.6e-06	3.61e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.58e-06	3.58e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.49e-06	3.37e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTEN—prostate cancer	1.38e-06	3.12e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—EP300—prostate cancer	1.32e-06	2.98e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—prostate cancer	1.22e-06	2.75e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.74e-07	2.2e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—prostate cancer	7.96e-07	1.8e-05	CbGpPWpGaD
